Free Trial

Arcus Biosciences (RCUS) Earnings Date, Estimates & Call Transcripts

Arcus Biosciences logo
$26.08 +0.04 (+0.13%)
Closing price 03:59 PM Eastern
Extended Trading
$24.18 -1.91 (-7.30%)
As of 06:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Arcus Biosciences Earnings Summary

Arcus Biosciences posted Q1 2026 earnings on May 5, 2026, reporting an EPS of -$1.02, which missed the consensus estimate of -$0.92 by $0.10. Quarterly revenue fell 39.3% year-over-year to $17 million, below the consensus estimate of $29.49 million. With a trailing EPS of -$3.30, Arcus Biosciences' earnings are expected to grow next year, from ($3.52) to ($2.88) per share.

Latest Q1
Earnings Date
May. 5Estimated
Consensus EPS
(May. 5)
-$0.92
Actual EPS
(May. 5)
-$1.02 Missed By -$0.10
Actual Revenue
(May. 5)
$17.00M

Q1 2026 Earnings Resources

Get Arcus Biosciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Arcus Biosciences and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

RCUS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

RCUS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Arcus Biosciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20263-$1.38-$0.87-$1.09
Q2 20263-$1.36-$0.93-$1.11
Q3 20263-$1.09-$1.00-$1.06
Q4 20263-$1.04-$1.01-$1.02

Arcus Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/5/2026Q1 2026-$0.92-$1.02 -$0.10-$1.02$29.49M$17.00M
2/25/2026Q4 2025-$1.11-$0.89+$0.22-$0.89$24.94M$33.00M
11/5/2025--$1.28-$1.27+$0.01-$20.25M-
10/28/2025Q3 2025-$1.33-$1.27+$0.06-$1.27$19.89M$26.00M
8/6/2025Q2 2025-$1.14-$1.1053+$0.0347-$32.86M$160.00M
5/6/2025Q1 2025-$1.02-$1.14 -$0.12-$1.14$38.61M$28.00M
2/25/2025Q4 2024-$1.17-$1.03+$0.14-$1.03$29.38M$36.00M
11/6/2024Q3 2024-$1.06-$1.00+$0.06-$1.00$38.95M$48.00M
8/8/2024Q2 2024-$1.02-$1.02--$1.02$26.24M$39.00M
5/8/2024Q1 2024-$0.97-$0.05+$0.92-$0.05$28.77M$145.00M

Data powered by Fiscal.ai.

Arcus Biosciences Earnings - Frequently Asked Questions

Arcus Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 5th, 2026 based off last year's report dates. Learn more on RCUS's earnings history.

In the previous quarter, Arcus Biosciences (NYSE:RCUS) missed the analysts' consensus estimate of ($0.92) by $0.10 with a reported earnings per share (EPS) of ($1.02). Learn more on analysts' earnings estimate vs. RCUS's actual earnings.

The conference call for Arcus Biosciences' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Arcus Biosciences' latest earnings report can be read online.
Read Transcript

Arcus Biosciences (NYSE:RCUS) has a recorded annual revenue of $247 million.

Arcus Biosciences (NYSE:RCUS) has a recorded net income of -$353 million. RCUS has generated -$3.30 earnings per share over the last four quarters.

Arcus Biosciences' earnings are expected to grow from ($3.52) per share to ($2.88) per share in the next year.


This page (NYSE:RCUS) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners